BWP
RVNC
Baldwin Wealth Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-500
| Closed | -$2.6K | – | 1080 |
|
|
2024
Q3 | $2.6K | Hold |
500
| – | – | ﹤0.01% | 927 |
|
|
2024
Q2 | $1.29K | Hold |
500
| – | – | ﹤0.01% | 703 |
|
|
2024
Q1 | $2.46K | Hold |
500
| – | – | ﹤0.01% | 637 |
|
|
2023
Q4 | $4.4K | Hold |
500
| – | – | ﹤0.01% | 625 |
|
|
2023
Q3 | $5.74K | Sell |
500
-1,500
| -75% | -$17.2K | ﹤0.01% | 615 |
|
|
2023
Q2 | $50.6K | Buy |
2,000
+1,500
| +300% | +$38K | ﹤0.01% | 414 |
|
|
2023
Q1 | $16.1K | Hold |
500
| – | – | ﹤0.01% | 570 |
|
|
2022
Q4 | $9.23K | Hold |
500
| – | – | ﹤0.01% | 615 |
|
|
2022
Q3 | $14K | Hold |
500
| – | – | ﹤0.01% | 488 |
|
|
2022
Q2 | $7K | Hold |
500
| – | – | ﹤0.01% | 574 |
|
|
2022
Q1 | $10K | Buy |
+500
| New | +$10K | ﹤0.01% | 544 |
|